Found: 9
Select item for more details and to access through your institution.
Tunnelled central venous catheter-related bloodstream infection in Canadian blood stem cell transplant recipients: Associated costs.
- Published in:
- Canadian Oncology Nursing Journal, 2015, v. 25, n. 3, p. 311, doi. 10.5737/23688076253311318
- By:
- Publication type:
- Article
Analysis of costs and benefits of transparent, gauze, or no dressing for a tunnelled central venous catheter in Canadian stem cell transplant recipients.
- Published in:
- Canadian Oncology Nursing Journal, 2015, v. 25, n. 3, p. 289, doi. 10.5737/23688076253289298
- By:
- Publication type:
- Article
Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 1, p. 19, doi. 10.1177/1078155213520261
- By:
- Publication type:
- Article
Chronic myeloid leukemia.
- Published in:
- Oncology Exchange, 2014, v. 13, n. 2, p. 25
- By:
- Publication type:
- Article
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment‐free remission after failing the first attempt with imatinib: Treatment‐free Remission Accomplished by Dasatinib (TRAD) study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 5, p. 781, doi. 10.1111/bjh.19058
- By:
- Publication type:
- Article
BCR–ABL1 transcript doubling time as a predictor for treatment‐free remission failure after imatinib discontinuation in chronic myeloid leukaemia in chronic phase.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 1, p. 136, doi. 10.1111/bjh.17807
- By:
- Publication type:
- Article
Optimal duration of imatinib treatment/deep molecular response for treatment‐free remission after imatinib discontinuation from a Canadian tyrosine kinase inhibitor discontinuation trial.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 779, doi. 10.1111/bjh.17447
- By:
- Publication type:
- Article
Toward optimization of cyclosporine concentration target to prevent acute graft‐versus‐host disease following myeloablative allogeneic stem cell transplant.
- Published in:
- Clinical Transplantation, 2022, v. 36, n. 8, p. 1, doi. 10.1111/ctr.14732
- By:
- Publication type:
- Article
Hairy cell leukemia.
- Published in:
- 2001
- By:
- Publication type:
- journal article